TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,026,593 | +0.9% | 4,849,812 | +2.5% | 0.02% | 0.0% |
| Q2 2023 | $74,335,384 | +3.7% | 4,731,724 | +8.7% | 0.02% | 0.0% |
| Q1 2023 | $71,712,778 | +16.2% | 4,351,503 | +10.0% | 0.02% | +7.1% |
| Q4 2022 | $61,690,262 | +11.3% | 3,954,504 | -7.4% | 0.01% | +7.7% |
| Q3 2022 | $55,414,000 | +8.6% | 4,272,469 | +17.5% | 0.01% | +8.3% |
| Q2 2022 | $51,033,000 | -16.0% | 3,634,781 | -14.3% | 0.01% | -7.7% |
| Q1 2022 | $60,755,000 | +19.4% | 4,242,689 | +13.7% | 0.01% | +30.0% |
| Q4 2021 | $50,878,000 | +22.6% | 3,732,803 | +47.3% | 0.01% | +11.1% |
| Q3 2021 | $41,515,000 | +35.4% | 2,534,519 | +39.1% | 0.01% | +28.6% |
| Q2 2021 | $30,663,000 | +4.0% | 1,821,883 | +12.8% | 0.01% | 0.0% |
| Q1 2021 | $29,484,000 | +1.4% | 1,614,700 | +1.0% | 0.01% | 0.0% |
| Q4 2020 | $29,082,000 | -3.4% | 1,597,949 | -5.3% | 0.01% | -22.2% |
| Q3 2020 | $30,117,000 | +63.7% | 1,688,146 | +64.5% | 0.01% | +50.0% |
| Q2 2020 | $18,401,000 | +59.7% | 1,026,260 | +35.2% | 0.01% | +50.0% |
| Q1 2020 | $11,520,000 | -70.6% | 758,881 | -61.7% | 0.00% | -60.0% |
| Q4 2019 | $39,140,000 | +10.5% | 1,983,789 | -3.7% | 0.01% | 0.0% |
| Q3 2019 | $35,423,000 | +283.2% | 2,059,459 | +294.3% | 0.01% | +233.3% |
| Q2 2019 | $9,245,000 | -83.6% | 522,311 | -81.1% | 0.00% | -82.4% |
| Q1 2019 | $56,302,000 | -34.6% | 2,763,970 | -46.0% | 0.02% | -37.0% |
| Q4 2018 | $86,129,000 | – | 5,120,619 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |